MAP Pharmaceuticals, Inc.

EDGAR

Market value is not computed: no listed ticker is recorded for this company.

28 filing records in this dataset, filed from 2007-11-19 to 2012-11-06. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 1980-01-02 to 2026-11-20; this is not a statement that none were filed.

Institutional holders (Form 13F)

Trades by members of Congress

See all insider transactions

Latest quarter

Revenue

878 thousand USD

2012 Q3 · USD

Exact inputs and evidence

Operating margin

-1,437.24%

2012 Q3 · %

Exact inputs and evidence
  • Operating Income: -12619000 USD Source
  • Revenue: 878000 USD Source

Operating cash flow

-10.6 million USD

2012 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -40029000 USD Source
  • Operating Cash Flow: -29430000 USD Source
Cash and cash equivalents
114 million USD Source
Exact value

114218000 USD

Long-term debt including current maturities
Not available
Shares outstanding
30.6 million shares Source
Exact value

30586336 shares

Reported share-count change

1.31% · 397 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 30189650 shares · 2010-12-31· Source
  • 30586336 shares · 2011-12-31· Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2012-11-06.

Financial data available through: 2011-12-31.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2011-12-31
  • Operating income: 3 of 11 periods available· newest 2011-12-31
  • Net income: 8 of 11 periods available· newest 2011-12-31
  • Operating cash flow: 3 of 11 periods available· newest 2011-12-31
  • Capital expenditure: 3 of 11 periods available· newest 2011-12-31
  • Total assets: 2 of 11 periods available· newest 2011-12-31
  • Total liabilities: 2 of 11 periods available· newest 2011-12-31
  • Current assets: 2 of 11 periods available· newest 2011-12-31
  • Current liabilities: 2 of 11 periods available· newest 2011-12-31
  • Cash and cash equivalents: 2 of 11 periods available· newest 2011-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 1 of 11 periods available· newest 2011-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    +USD 21.73 million

    Prior period

    −USD 54.67 million

    –

    Current period

    −USD 32.94 million

    –

    Exact inputs and evidence

    -32939000 − -54673000 = 21734000 USD

    -54673000 USD · 2010-01-01 – 2010-12-31

    Inspect prior input Prior source

    -32939000 USD · 2011-01-01 – 2011-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 79.08 million

    Prior period

    −USD 49.36 million

    –

    Current period

    USD 29.72 million

    –

    Exact inputs and evidence

    29717000 − -49363000 = 79080000 USD

    -49363000 USD · 2010-01-01 – 2010-12-31

    Inspect prior input Prior source

    29717000 USD · 2011-01-01 – 2011-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -15.7%

    Prior period

    USD 2.08 million

    –

    Current period

    USD 1.75 million

    –

    Exact inputs and evidence

    1754000 − 2080000 = -326000 USD

    2080000 USD · 2010-01-01 – 2010-12-31

    Inspect prior input Prior source

    1754000 USD · 2011-01-01 – 2011-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2011 2011-01-01 – 2011-12-31

  • Revenue USD 23.07 million 100% of revenue
  • Operating costs Derived USD 55.72 million 242% of revenue
  • Operating income −USD 32.65 million −142% of revenue
  • Tax, interest and other Derived USD 285,000 1.2% of revenue
  • Net income −USD 32.94 million −143% of revenue

Cash

  • Operating cash flow USD 29.72 million 129% of revenue
  • Capital expenditure USD 1.75 million 7.6% of revenue
  • Free cash flow Derived USD 27.96 million 121% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2009 Operating loss: operating costs were 113% of revenue.
  • 2011 Operating loss: operating costs were 242% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2009 2009-01-01 – 2009-12-3154166000 61135000 Derived -6969000 2028000 Derived -8997000 -5324000 Derived
Source
2011 2011-01-01 – 2011-12-3123069000 55723000 Derived -32654000 285000 Derived -32939000 27963000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 23.1M 2011
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.58.5M43.9M29.2M14.6M0.020092011
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2009Revenue54166000
2011Revenue23069000

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2009Year over yearNo prior comparable period
2011Year over yearNo prior comparable period

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -141.5% 2011
Net margin -142.8% 2011
Free cash flow margin 121.2% 2011
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.142%66%-11%-87%-164%20092011
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2009Operating margin-12.9%
2011Operating margin-141.5%
2009Net margin-16.6%
2011Net margin-142.8%
2009Free cash flow margin-9.8%
2011Free cash flow margin121.2%

Operating cash flow

Cash generated by the company’s normal business operations.

USD 29.7M 2011
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.32.4M22.6M12.9M3.1M-6.7M20092011
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2009Operating cash flow-4008000
2011Operating cash flow29717000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 28M 2011
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.30.6M21.0M11.3M1.7M-8.0M20092011
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2009Free cash flow-5324000
2011Free cash flow27963000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

63.2% 2011
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.68%51%34%17%0%20092011
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2009Liabilities / assets41.1%
2011Liabilities / assets63.2%

Current assets to current liabilities

Current assets divided by current liabilities.

7.09× 2011
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.7.65×5.74×3.83×1.91×0.00×20092011
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2009Current assets / current liabilities3.05×
2011Current assets / current liabilities7.09×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2004 2004-01-01 – 2004-12-31
−USD 8.83 million
Exact value

Exact value: -8831000 USD

2004-01-01 – 2004-12-31: -8831000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

2005 2005-01-01 – 2005-12-31
−USD 16.25 million
Exact value

Exact value: -16249000 USD

2005-01-01 – 2005-12-31: -16249000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

2006 2006-01-01 – 2006-12-31
−USD 25.81 million
Exact value

Exact value: -25809000 USD

2006-01-01 – 2006-12-31: -25809000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

2007 2007-01-01 – 2007-12-31
−USD 40.06 million
Exact value

Exact value: -40060000 USD

2007-01-01 – 2007-12-31: -40060000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

2008 2008-01-01 – 2008-12-31
−USD 72.93 million
Exact value

Exact value: -72928000 USD

2008-01-01 – 2008-12-31: -72928000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

2009 2009-01-01 – 2009-12-31
−USD 9 million
Exact value

Exact value: -8997000 USD

2009-01-01 – 2009-12-31: -8997000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 4.01 million
Exact value

Exact value: -4008000 USD

2009-01-01 – 2009-12-31: -4008000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.32 million
Exact value

Exact value: 1316000 USD

2009-01-01 – 2009-12-31: 1316000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 5.32 million
Calculation and evidence

-4008000 − 1316000 USD

Exact free cash flow: -5324000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2010 2010-01-01 – 2010-12-31
−USD 54.67 million
Exact value

Exact value: -54673000 USD

2010-01-01 – 2010-12-31: -54673000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 49.36 million
Exact value

Exact value: -49363000 USD

2010-01-01 – 2010-12-31: -49363000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2.08 million
Exact value

Exact value: 2080000 USD

2010-01-01 – 2010-12-31: 2080000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 51.44 million
Calculation and evidence

-49363000 − 2080000 USD

Exact free cash flow: -51443000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2011 2011-01-01 – 2011-12-31
−USD 32.94 million
Exact value

Exact value: -32939000 USD

2011-01-01 – 2011-12-31: -32939000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 29.72 million
Exact value

Exact value: 29717000 USD

2011-01-01 – 2011-12-31: 29717000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.75 million
Exact value

Exact value: 1754000 USD

2011-01-01 – 2011-12-31: 1754000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 27.96 million
Calculation and evidence

29717000 − 1754000 USD

Exact free cash flow: 27963000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

28 filings · 763 latest values · 763 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001401923, 1401923, edgar:1401923

Also known as MAP Pharmaceuticals, Inc.